nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—Alopecia—Pamidronate—osteoporosis	0.000872	0.00184	CcSEcCtD
Lithium—Nausea—Ergocalciferol—osteoporosis	0.000862	0.00182	CcSEcCtD
Lithium—Abdominal pain—Etidronic acid—osteoporosis	0.000853	0.0018	CcSEcCtD
Lithium—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00085	0.0018	CcSEcCtD
Lithium—Angioedema—Ethinyl Estradiol—osteoporosis	0.000847	0.00179	CcSEcCtD
Lithium—Dysgeusia—Pamidronate—osteoporosis	0.000841	0.00178	CcSEcCtD
Lithium—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000837	0.00177	CcSEcCtD
Lithium—Anorexia—Calcitriol—osteoporosis	0.000835	0.00176	CcSEcCtD
Lithium—Somnolence—Estropipate—osteoporosis	0.00083	0.00175	CcSEcCtD
Lithium—Angioedema—Risedronate—osteoporosis	0.000826	0.00174	CcSEcCtD
Lithium—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000824	0.00174	CcSEcCtD
Lithium—Dyspepsia—Estropipate—osteoporosis	0.000821	0.00173	CcSEcCtD
Lithium—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000815	0.00172	CcSEcCtD
Lithium—Vertigo—Risedronate—osteoporosis	0.000812	0.00171	CcSEcCtD
Lithium—Syncope—Risedronate—osteoporosis	0.00081	0.00171	CcSEcCtD
Lithium—Dyspepsia—Alendronate—osteoporosis	0.000809	0.00171	CcSEcCtD
Lithium—Arrhythmia—Zoledronate—osteoporosis	0.000805	0.0017	CcSEcCtD
Lithium—Fatigue—Estropipate—osteoporosis	0.000805	0.0017	CcSEcCtD
Lithium—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000798	0.00169	CcSEcCtD
Lithium—Alopecia—Zoledronate—osteoporosis	0.000796	0.00168	CcSEcCtD
Lithium—Dyspepsia—Raloxifene—osteoporosis	0.000796	0.00168	CcSEcCtD
Lithium—Loss of consciousness—Risedronate—osteoporosis	0.000794	0.00168	CcSEcCtD
Lithium—Weight increased—Estradiol—osteoporosis	0.00079	0.00167	CcSEcCtD
Lithium—Agitation—Pamidronate—osteoporosis	0.000789	0.00167	CcSEcCtD
Lithium—Dyspepsia—Ibandronate—osteoporosis	0.000788	0.00166	CcSEcCtD
Lithium—Weight decreased—Estradiol—osteoporosis	0.000785	0.00166	CcSEcCtD
Lithium—Angioedema—Pamidronate—osteoporosis	0.000785	0.00166	CcSEcCtD
Lithium—Hyperglycaemia—Estradiol—osteoporosis	0.000783	0.00165	CcSEcCtD
Lithium—Discomfort—Ethinyl Estradiol—osteoporosis	0.00078	0.00165	CcSEcCtD
Lithium—Somnolence—Calcitriol—osteoporosis	0.000779	0.00164	CcSEcCtD
Lithium—Decreased appetite—Ibandronate—osteoporosis	0.000778	0.00164	CcSEcCtD
Lithium—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000775	0.00164	CcSEcCtD
Lithium—Fatigue—Ibandronate—osteoporosis	0.000772	0.00163	CcSEcCtD
Lithium—Syncope—Pamidronate—osteoporosis	0.00077	0.00163	CcSEcCtD
Lithium—Arthralgia—Risedronate—osteoporosis	0.000769	0.00162	CcSEcCtD
Lithium—Dysgeusia—Zoledronate—osteoporosis	0.000768	0.00162	CcSEcCtD
Lithium—Alopecia—Conjugated Estrogens—osteoporosis	0.000767	0.00162	CcSEcCtD
Lithium—Gastrointestinal pain—Estropipate—osteoporosis	0.000763	0.00161	CcSEcCtD
Lithium—Decreased appetite—Calcitriol—osteoporosis	0.000761	0.00161	CcSEcCtD
Lithium—Feeling abnormal—Alendronate—osteoporosis	0.000757	0.0016	CcSEcCtD
Lithium—Oedema—Ethinyl Estradiol—osteoporosis	0.000756	0.0016	CcSEcCtD
Lithium—Loss of consciousness—Pamidronate—osteoporosis	0.000755	0.00159	CcSEcCtD
Lithium—Dry mouth—Risedronate—osteoporosis	0.000752	0.00159	CcSEcCtD
Lithium—Gastrointestinal pain—Alendronate—osteoporosis	0.000752	0.00159	CcSEcCtD
Lithium—Flatulence—Conjugated Estrogens—osteoporosis	0.000744	0.00157	CcSEcCtD
Lithium—Convulsion—Pamidronate—osteoporosis	0.000744	0.00157	CcSEcCtD
Lithium—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00074	0.00156	CcSEcCtD
Lithium—Vision blurred—Zoledronate—osteoporosis	0.000739	0.00156	CcSEcCtD
Lithium—Gastrointestinal pain—Raloxifene—osteoporosis	0.000739	0.00156	CcSEcCtD
Lithium—Diarrhoea—Etidronic acid—osteoporosis	0.000738	0.00156	CcSEcCtD
Lithium—Body temperature increased—Estropipate—osteoporosis	0.000738	0.00156	CcSEcCtD
Lithium—Abdominal pain—Estropipate—osteoporosis	0.000738	0.00156	CcSEcCtD
Lithium—Feeling abnormal—Ibandronate—osteoporosis	0.000737	0.00156	CcSEcCtD
Lithium—Tremor—Zoledronate—osteoporosis	0.000735	0.00155	CcSEcCtD
Lithium—Gastrointestinal pain—Ibandronate—osteoporosis	0.000732	0.00155	CcSEcCtD
Lithium—Arthralgia—Pamidronate—osteoporosis	0.000731	0.00154	CcSEcCtD
Lithium—Abdominal pain—Alendronate—osteoporosis	0.000727	0.00153	CcSEcCtD
Lithium—Body temperature increased—Alendronate—osteoporosis	0.000727	0.00153	CcSEcCtD
Lithium—Shock—Risedronate—osteoporosis	0.000726	0.00153	CcSEcCtD
Lithium—Discomfort—Pamidronate—osteoporosis	0.000723	0.00153	CcSEcCtD
Lithium—Agitation—Zoledronate—osteoporosis	0.000721	0.00152	CcSEcCtD
Lithium—Angioedema—Zoledronate—osteoporosis	0.000717	0.00151	CcSEcCtD
Lithium—Gastrointestinal pain—Calcitriol—osteoporosis	0.000716	0.00151	CcSEcCtD
Lithium—Abdominal pain—Raloxifene—osteoporosis	0.000715	0.00151	CcSEcCtD
Lithium—Body temperature increased—Raloxifene—osteoporosis	0.000715	0.00151	CcSEcCtD
Lithium—Vision blurred—Conjugated Estrogens—osteoporosis	0.000712	0.0015	CcSEcCtD
Lithium—Abdominal pain—Ibandronate—osteoporosis	0.000707	0.00149	CcSEcCtD
Lithium—Body temperature increased—Ibandronate—osteoporosis	0.000707	0.00149	CcSEcCtD
Lithium—Confusional state—Pamidronate—osteoporosis	0.000707	0.00149	CcSEcCtD
Lithium—Vertigo—Zoledronate—osteoporosis	0.000705	0.00149	CcSEcCtD
Lithium—Syncope—Zoledronate—osteoporosis	0.000704	0.00149	CcSEcCtD
Lithium—Oedema—Pamidronate—osteoporosis	0.000701	0.00148	CcSEcCtD
Lithium—Abdominal pain—Calcitriol—osteoporosis	0.000692	0.00146	CcSEcCtD
Lithium—Body temperature increased—Calcitriol—osteoporosis	0.000692	0.00146	CcSEcCtD
Lithium—Angioedema—Conjugated Estrogens—osteoporosis	0.00069	0.00146	CcSEcCtD
Lithium—Shock—Pamidronate—osteoporosis	0.00069	0.00146	CcSEcCtD
Lithium—Loss of consciousness—Zoledronate—osteoporosis	0.00069	0.00146	CcSEcCtD
Lithium—Vomiting—Etidronic acid—osteoporosis	0.000686	0.00145	CcSEcCtD
Lithium—Rash—Etidronic acid—osteoporosis	0.00068	0.00144	CcSEcCtD
Lithium—Convulsion—Zoledronate—osteoporosis	0.00068	0.00144	CcSEcCtD
Lithium—Dermatitis—Etidronic acid—osteoporosis	0.000679	0.00144	CcSEcCtD
Lithium—Vertigo—Conjugated Estrogens—osteoporosis	0.000679	0.00143	CcSEcCtD
Lithium—Syncope—Conjugated Estrogens—osteoporosis	0.000678	0.00143	CcSEcCtD
Lithium—Headache—Etidronic acid—osteoporosis	0.000676	0.00143	CcSEcCtD
Lithium—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000672	0.00142	CcSEcCtD
Lithium—Asthenia—Estropipate—osteoporosis	0.00067	0.00141	CcSEcCtD
Lithium—Anorexia—Pamidronate—osteoporosis	0.000668	0.00141	CcSEcCtD
Lithium—Arthralgia—Zoledronate—osteoporosis	0.000668	0.00141	CcSEcCtD
Lithium—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000664	0.0014	CcSEcCtD
Lithium—Discomfort—Zoledronate—osteoporosis	0.00066	0.00139	CcSEcCtD
Lithium—Asthenia—Alendronate—osteoporosis	0.000659	0.00139	CcSEcCtD
Lithium—Hypotension—Pamidronate—osteoporosis	0.000655	0.00138	CcSEcCtD
Lithium—Convulsion—Conjugated Estrogens—osteoporosis	0.000655	0.00138	CcSEcCtD
Lithium—Dry mouth—Zoledronate—osteoporosis	0.000653	0.00138	CcSEcCtD
Lithium—Fatigue—Ethinyl Estradiol—osteoporosis	0.000652	0.00138	CcSEcCtD
Lithium—Dyspepsia—Risedronate—osteoporosis	0.000649	0.00137	CcSEcCtD
Lithium—Tinnitus—Estradiol—osteoporosis	0.000648	0.00137	CcSEcCtD
Lithium—Confusional state—Zoledronate—osteoporosis	0.000646	0.00136	CcSEcCtD
Lithium—Arthralgia—Conjugated Estrogens—osteoporosis	0.000643	0.00136	CcSEcCtD
Lithium—Asthenia—Ibandronate—osteoporosis	0.000642	0.00136	CcSEcCtD
Lithium—Nausea—Etidronic acid—osteoporosis	0.000641	0.00135	CcSEcCtD
Lithium—Oedema—Zoledronate—osteoporosis	0.00064	0.00135	CcSEcCtD
Lithium—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000639	0.00135	CcSEcCtD
Lithium—Diarrhoea—Estropipate—osteoporosis	0.000638	0.00135	CcSEcCtD
Lithium—Fatigue—Risedronate—osteoporosis	0.000636	0.00134	CcSEcCtD
Lithium—Shock—Zoledronate—osteoporosis	0.00063	0.00133	CcSEcCtD
Lithium—Diarrhoea—Alendronate—osteoporosis	0.000629	0.00133	CcSEcCtD
Lithium—Asthenia—Calcitriol—osteoporosis	0.000629	0.00133	CcSEcCtD
Lithium—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000623	0.00132	CcSEcCtD
Lithium—Somnolence—Pamidronate—osteoporosis	0.000623	0.00132	CcSEcCtD
Lithium—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000619	0.00131	CcSEcCtD
Lithium—Diarrhoea—Raloxifene—osteoporosis	0.000618	0.00131	CcSEcCtD
Lithium—Dyspepsia—Pamidronate—osteoporosis	0.000617	0.0013	CcSEcCtD
Lithium—Dizziness—Estropipate—osteoporosis	0.000617	0.0013	CcSEcCtD
Lithium—Oedema—Conjugated Estrogens—osteoporosis	0.000617	0.0013	CcSEcCtD
Lithium—Alopecia—Estradiol—osteoporosis	0.000614	0.0013	CcSEcCtD
Lithium—Diarrhoea—Ibandronate—osteoporosis	0.000612	0.00129	CcSEcCtD
Lithium—Anorexia—Zoledronate—osteoporosis	0.00061	0.00129	CcSEcCtD
Lithium—Decreased appetite—Pamidronate—osteoporosis	0.000609	0.00129	CcSEcCtD
Lithium—Dizziness—Alendronate—osteoporosis	0.000608	0.00128	CcSEcCtD
Lithium—Shock—Conjugated Estrogens—osteoporosis	0.000607	0.00128	CcSEcCtD
Lithium—Fatigue—Pamidronate—osteoporosis	0.000604	0.00128	CcSEcCtD
Lithium—Gastrointestinal pain—Risedronate—osteoporosis	0.000603	0.00127	CcSEcCtD
Lithium—Diarrhoea—Calcitriol—osteoporosis	0.000599	0.00127	CcSEcCtD
Lithium—Hypotension—Zoledronate—osteoporosis	0.000598	0.00126	CcSEcCtD
Lithium—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000598	0.00126	CcSEcCtD
Lithium—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000598	0.00126	CcSEcCtD
Lithium—Dizziness—Raloxifene—osteoporosis	0.000598	0.00126	CcSEcCtD
Lithium—Flatulence—Estradiol—osteoporosis	0.000596	0.00126	CcSEcCtD
Lithium—Vomiting—Estropipate—osteoporosis	0.000593	0.00125	CcSEcCtD
Lithium—Dysgeusia—Estradiol—osteoporosis	0.000592	0.00125	CcSEcCtD
Lithium—Dizziness—Ibandronate—osteoporosis	0.000592	0.00125	CcSEcCtD
Lithium—Rash—Estropipate—osteoporosis	0.000588	0.00124	CcSEcCtD
Lithium—Dermatitis—Estropipate—osteoporosis	0.000588	0.00124	CcSEcCtD
Lithium—Anorexia—Conjugated Estrogens—osteoporosis	0.000588	0.00124	CcSEcCtD
Lithium—Headache—Estropipate—osteoporosis	0.000585	0.00123	CcSEcCtD
Lithium—Vomiting—Alendronate—osteoporosis	0.000584	0.00123	CcSEcCtD
Lithium—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000583	0.00123	CcSEcCtD
Lithium—Abdominal pain—Risedronate—osteoporosis	0.000583	0.00123	CcSEcCtD
Lithium—Body temperature increased—Risedronate—osteoporosis	0.000583	0.00123	CcSEcCtD
Lithium—Rash—Alendronate—osteoporosis	0.00058	0.00122	CcSEcCtD
Lithium—Dermatitis—Alendronate—osteoporosis	0.000579	0.00122	CcSEcCtD
Lithium—Feeling abnormal—Pamidronate—osteoporosis	0.000578	0.00122	CcSEcCtD
Lithium—Hypotension—Conjugated Estrogens—osteoporosis	0.000576	0.00122	CcSEcCtD
Lithium—Headache—Alendronate—osteoporosis	0.000576	0.00122	CcSEcCtD
Lithium—Vomiting—Raloxifene—osteoporosis	0.000575	0.00121	CcSEcCtD
Lithium—Gastrointestinal pain—Pamidronate—osteoporosis	0.000573	0.00121	CcSEcCtD
Lithium—Rash—Raloxifene—osteoporosis	0.00057	0.0012	CcSEcCtD
Lithium—Dermatitis—Raloxifene—osteoporosis	0.000569	0.0012	CcSEcCtD
Lithium—Somnolence—Zoledronate—osteoporosis	0.000569	0.0012	CcSEcCtD
Lithium—Vomiting—Ibandronate—osteoporosis	0.000569	0.0012	CcSEcCtD
Lithium—Tremor—Estradiol—osteoporosis	0.000567	0.0012	CcSEcCtD
Lithium—Headache—Raloxifene—osteoporosis	0.000566	0.0012	CcSEcCtD
Lithium—Rash—Ibandronate—osteoporosis	0.000564	0.00119	CcSEcCtD
Lithium—Dermatitis—Ibandronate—osteoporosis	0.000564	0.00119	CcSEcCtD
Lithium—Dyspepsia—Zoledronate—osteoporosis	0.000564	0.00119	CcSEcCtD
Lithium—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000562	0.00119	CcSEcCtD
Lithium—Headache—Ibandronate—osteoporosis	0.000561	0.00118	CcSEcCtD
Lithium—Vomiting—Calcitriol—osteoporosis	0.000557	0.00118	CcSEcCtD
Lithium—Decreased appetite—Zoledronate—osteoporosis	0.000557	0.00118	CcSEcCtD
Lithium—Agitation—Estradiol—osteoporosis	0.000556	0.00117	CcSEcCtD
Lithium—Nausea—Estropipate—osteoporosis	0.000554	0.00117	CcSEcCtD
Lithium—Abdominal pain—Pamidronate—osteoporosis	0.000554	0.00117	CcSEcCtD
Lithium—Body temperature increased—Pamidronate—osteoporosis	0.000554	0.00117	CcSEcCtD
Lithium—Angioedema—Estradiol—osteoporosis	0.000553	0.00117	CcSEcCtD
Lithium—Rash—Calcitriol—osteoporosis	0.000552	0.00117	CcSEcCtD
Lithium—Fatigue—Zoledronate—osteoporosis	0.000552	0.00117	CcSEcCtD
Lithium—Dermatitis—Calcitriol—osteoporosis	0.000552	0.00117	CcSEcCtD
Lithium—Headache—Calcitriol—osteoporosis	0.000549	0.00116	CcSEcCtD
Lithium—Somnolence—Conjugated Estrogens—osteoporosis	0.000548	0.00116	CcSEcCtD
Lithium—Nausea—Alendronate—osteoporosis	0.000546	0.00115	CcSEcCtD
Lithium—Vertigo—Estradiol—osteoporosis	0.000543	0.00115	CcSEcCtD
Lithium—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000543	0.00115	CcSEcCtD
Lithium—Asthenia—Ethinyl Estradiol—osteoporosis	0.000543	0.00115	CcSEcCtD
Lithium—Syncope—Estradiol—osteoporosis	0.000542	0.00115	CcSEcCtD
Lithium—Nausea—Raloxifene—osteoporosis	0.000537	0.00113	CcSEcCtD
Lithium—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000536	0.00113	CcSEcCtD
Lithium—Fatigue—Conjugated Estrogens—osteoporosis	0.000532	0.00112	CcSEcCtD
Lithium—Nausea—Ibandronate—osteoporosis	0.000532	0.00112	CcSEcCtD
Lithium—Loss of consciousness—Estradiol—osteoporosis	0.000531	0.00112	CcSEcCtD
Lithium—Asthenia—Risedronate—osteoporosis	0.000529	0.00112	CcSEcCtD
Lithium—Feeling abnormal—Zoledronate—osteoporosis	0.000528	0.00111	CcSEcCtD
Lithium—Gastrointestinal pain—Zoledronate—osteoporosis	0.000524	0.00111	CcSEcCtD
Lithium—Nausea—Calcitriol—osteoporosis	0.00052	0.0011	CcSEcCtD
Lithium—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000518	0.00109	CcSEcCtD
Lithium—Arthralgia—Estradiol—osteoporosis	0.000515	0.00109	CcSEcCtD
Lithium—Discomfort—Estradiol—osteoporosis	0.000509	0.00107	CcSEcCtD
Lithium—Body temperature increased—Zoledronate—osteoporosis	0.000506	0.00107	CcSEcCtD
Lithium—Abdominal pain—Zoledronate—osteoporosis	0.000506	0.00107	CcSEcCtD
Lithium—Diarrhoea—Risedronate—osteoporosis	0.000505	0.00107	CcSEcCtD
Lithium—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000504	0.00106	CcSEcCtD
Lithium—Dry mouth—Estradiol—osteoporosis	0.000503	0.00106	CcSEcCtD
Lithium—Asthenia—Pamidronate—osteoporosis	0.000503	0.00106	CcSEcCtD
Lithium—Dizziness—Ethinyl Estradiol—osteoporosis	0.0005	0.00106	CcSEcCtD
Lithium—Confusional state—Estradiol—osteoporosis	0.000498	0.00105	CcSEcCtD
Lithium—Oedema—Estradiol—osteoporosis	0.000493	0.00104	CcSEcCtD
Lithium—Dizziness—Risedronate—osteoporosis	0.000488	0.00103	CcSEcCtD
Lithium—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000487	0.00103	CcSEcCtD
Lithium—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000487	0.00103	CcSEcCtD
Lithium—Shock—Estradiol—osteoporosis	0.000486	0.00103	CcSEcCtD
Lithium—Vomiting—Ethinyl Estradiol—osteoporosis	0.000481	0.00102	CcSEcCtD
Lithium—Diarrhoea—Pamidronate—osteoporosis	0.00048	0.00101	CcSEcCtD
Lithium—Rash—Ethinyl Estradiol—osteoporosis	0.000477	0.00101	CcSEcCtD
Lithium—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000476	0.00101	CcSEcCtD
Lithium—Headache—Ethinyl Estradiol—osteoporosis	0.000474	0.001	CcSEcCtD
Lithium—Vomiting—Risedronate—osteoporosis	0.000469	0.00099	CcSEcCtD
Lithium—Rash—Risedronate—osteoporosis	0.000465	0.000982	CcSEcCtD
Lithium—Dermatitis—Risedronate—osteoporosis	0.000465	0.000981	CcSEcCtD
Lithium—Dizziness—Pamidronate—osteoporosis	0.000464	0.000979	CcSEcCtD
Lithium—Headache—Risedronate—osteoporosis	0.000462	0.000976	CcSEcCtD
Lithium—Asthenia—Zoledronate—osteoporosis	0.000459	0.00097	CcSEcCtD
Lithium—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00045	0.00095	CcSEcCtD
Lithium—Nausea—Ethinyl Estradiol—osteoporosis	0.000449	0.000949	CcSEcCtD
Lithium—Vomiting—Pamidronate—osteoporosis	0.000446	0.000941	CcSEcCtD
Lithium—Asthenia—Conjugated Estrogens—osteoporosis	0.000442	0.000934	CcSEcCtD
Lithium—Rash—Pamidronate—osteoporosis	0.000442	0.000934	CcSEcCtD
Lithium—Dermatitis—Pamidronate—osteoporosis	0.000442	0.000933	CcSEcCtD
Lithium—Headache—Pamidronate—osteoporosis	0.000439	0.000928	CcSEcCtD
Lithium—Somnolence—Estradiol—osteoporosis	0.000439	0.000927	CcSEcCtD
Lithium—Diarrhoea—Zoledronate—osteoporosis	0.000438	0.000925	CcSEcCtD
Lithium—Nausea—Risedronate—osteoporosis	0.000438	0.000925	CcSEcCtD
Lithium—Dyspepsia—Estradiol—osteoporosis	0.000434	0.000917	CcSEcCtD
Lithium—Decreased appetite—Estradiol—osteoporosis	0.000429	0.000906	CcSEcCtD
Lithium—Fatigue—Estradiol—osteoporosis	0.000425	0.000899	CcSEcCtD
Lithium—Dizziness—Zoledronate—osteoporosis	0.000423	0.000894	CcSEcCtD
Lithium—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000422	0.000891	CcSEcCtD
Lithium—Nausea—Pamidronate—osteoporosis	0.000416	0.000879	CcSEcCtD
Lithium—Dizziness—Conjugated Estrogens—osteoporosis	0.000408	0.000861	CcSEcCtD
Lithium—Vomiting—Zoledronate—osteoporosis	0.000407	0.00086	CcSEcCtD
Lithium—Feeling abnormal—Estradiol—osteoporosis	0.000407	0.000859	CcSEcCtD
Lithium—Rash—Zoledronate—osteoporosis	0.000404	0.000853	CcSEcCtD
Lithium—Gastrointestinal pain—Estradiol—osteoporosis	0.000404	0.000852	CcSEcCtD
Lithium—Dermatitis—Zoledronate—osteoporosis	0.000403	0.000852	CcSEcCtD
Lithium—Headache—Zoledronate—osteoporosis	0.000401	0.000847	CcSEcCtD
Lithium—Vomiting—Conjugated Estrogens—osteoporosis	0.000392	0.000828	CcSEcCtD
Lithium—Body temperature increased—Estradiol—osteoporosis	0.00039	0.000824	CcSEcCtD
Lithium—Abdominal pain—Estradiol—osteoporosis	0.00039	0.000824	CcSEcCtD
Lithium—Rash—Conjugated Estrogens—osteoporosis	0.000389	0.000821	CcSEcCtD
Lithium—Dermatitis—Conjugated Estrogens—osteoporosis	0.000388	0.00082	CcSEcCtD
Lithium—Headache—Conjugated Estrogens—osteoporosis	0.000386	0.000816	CcSEcCtD
Lithium—Nausea—Zoledronate—osteoporosis	0.00038	0.000803	CcSEcCtD
Lithium—Nausea—Conjugated Estrogens—osteoporosis	0.000366	0.000773	CcSEcCtD
Lithium—GSK3B—DAP12 interactions—IL6R—osteoporosis	0.000366	0.000696	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6R—osteoporosis	0.000366	0.000696	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6R—osteoporosis	0.000366	0.000696	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—TGFB1—osteoporosis	0.000365	0.000694	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6R—osteoporosis	0.000363	0.000689	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—IRS1—osteoporosis	0.000361	0.000685	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—RAP1A—osteoporosis	0.000361	0.000685	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ADCY5—osteoporosis	0.00036	0.000684	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6R—osteoporosis	0.00036	0.000683	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IRS1—osteoporosis	0.000359	0.000683	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GPX1—osteoporosis	0.000359	0.000682	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6R—osteoporosis	0.000358	0.00068	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CTSK—osteoporosis	0.000358	0.000679	CbGpPWpGaD
Lithium—GSK3A—Immune System—ACTG1—osteoporosis	0.000354	0.000673	CbGpPWpGaD
Lithium—Asthenia—Estradiol—osteoporosis	0.000354	0.000748	CcSEcCtD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—MYC—osteoporosis	0.000351	0.000667	CbGpPWpGaD
Lithium—GSK3B—Disease—GSN—osteoporosis	0.000349	0.000662	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—ADCY5—osteoporosis	0.000348	0.00066	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IRS1—osteoporosis	0.000345	0.000656	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—KL—osteoporosis	0.000343	0.000651	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—IGF1—osteoporosis	0.000341	0.000648	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—MYC—osteoporosis	0.00034	0.000646	CbGpPWpGaD
Lithium—Diarrhoea—Estradiol—osteoporosis	0.000338	0.000713	CcSEcCtD
Lithium—GSK3A—Signaling by NGF—IL6R—osteoporosis	0.000338	0.000641	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway and Pluripotency—MYC—osteoporosis	0.000337	0.000641	CbGpPWpGaD
Lithium—GSK3B—Cell Cycle—TGFB1—osteoporosis	0.000336	0.000639	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—MYC—osteoporosis	0.000333	0.000633	CbGpPWpGaD
Lithium—IMPA2—Metabolism—MTHFR—osteoporosis	0.000331	0.000629	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—KL—osteoporosis	0.000329	0.000625	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—TGFB1—osteoporosis	0.000329	0.000624	CbGpPWpGaD
Lithium—GSK3A—Disease—ACP5—osteoporosis	0.000327	0.000621	CbGpPWpGaD
Lithium—Dizziness—Estradiol—osteoporosis	0.000326	0.000689	CcSEcCtD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6R—osteoporosis	0.000324	0.000616	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—ACE—osteoporosis	0.000323	0.000614	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ADCY5—osteoporosis	0.000321	0.00061	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GPX1—osteoporosis	0.00032	0.000608	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—MYC—osteoporosis	0.00032	0.000607	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—TGFB1—osteoporosis	0.000319	0.000606	CbGpPWpGaD
Lithium—Vomiting—Estradiol—osteoporosis	0.000314	0.000663	CcSEcCtD
Lithium—Rash—Estradiol—osteoporosis	0.000311	0.000657	CcSEcCtD
Lithium—Dermatitis—Estradiol—osteoporosis	0.000311	0.000657	CcSEcCtD
Lithium—Headache—Estradiol—osteoporosis	0.000309	0.000653	CcSEcCtD
Lithium—GSK3B—Signaling by NGF—IRS2—osteoporosis	0.000304	0.000578	CbGpPWpGaD
Lithium—GSK3A—Disease—TPI1—osteoporosis	0.000304	0.000578	CbGpPWpGaD
Lithium—GSK3B—Disease—LRP5—osteoporosis	0.000303	0.000576	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SOST—osteoporosis	0.000303	0.000575	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.000302	0.000573	CbGpPWpGaD
Lithium—GSK3A—Immune System—RAP1A—osteoporosis	0.000296	0.000562	CbGpPWpGaD
Lithium—IMPA1—Metabolism—MTHFR—osteoporosis	0.000295	0.000561	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MGLL—osteoporosis	0.000295	0.000559	CbGpPWpGaD
Lithium—GSK3A—Immune System—CTSK—osteoporosis	0.000294	0.000558	CbGpPWpGaD
Lithium—Nausea—Estradiol—osteoporosis	0.000293	0.000619	CcSEcCtD
Lithium—GSK3B—Disease—LRP6—osteoporosis	0.00029	0.000551	CbGpPWpGaD
Lithium—GSK3A—Immune System—NFATC1—osteoporosis	0.000289	0.000548	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LRP5—osteoporosis	0.000287	0.000546	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PSMA2—osteoporosis	0.000287	0.000546	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PSMA5—osteoporosis	0.000287	0.000546	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRAK3—osteoporosis	0.000286	0.000544	CbGpPWpGaD
Lithium—GSK3A—Disease—P4HB—osteoporosis	0.000286	0.000543	CbGpPWpGaD
Lithium—GSK3A—Disease—GAPDH—osteoporosis	0.000281	0.000533	CbGpPWpGaD
Lithium—GSK3B—Disease—LTF—osteoporosis	0.000279	0.000529	CbGpPWpGaD
Lithium—GSK3B—Disease—RPL24—osteoporosis	0.000279	0.000529	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000276	0.000525	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000276	0.000524	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LRP6—osteoporosis	0.000275	0.000522	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CALCR—osteoporosis	0.000274	0.00052	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTH1R—osteoporosis	0.000274	0.00052	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AGER—osteoporosis	0.000269	0.000511	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—ADCY5—osteoporosis	0.000268	0.00051	CbGpPWpGaD
Lithium—GSK3A—Disease—NFATC1—osteoporosis	0.000267	0.000506	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IRS1—osteoporosis	0.000266	0.000504	CbGpPWpGaD
Lithium—IMPA2—Metabolism—POMC—osteoporosis	0.000265	0.000503	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—IL6—osteoporosis	0.000265	0.000503	CbGpPWpGaD
Lithium—GSK3A—Disease—DKK1—osteoporosis	0.000265	0.000502	CbGpPWpGaD
Lithium—GSK3B—Immune System—ACTG1—osteoporosis	0.000262	0.000497	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000257	0.000489	CbGpPWpGaD
Lithium—GSK3A—Disease—WNT1—osteoporosis	0.000255	0.000484	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—IL6—osteoporosis	0.000253	0.000481	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—KL—osteoporosis	0.000253	0.000481	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6R—osteoporosis	0.000249	0.000474	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—IL6—osteoporosis	0.000249	0.000474	CbGpPWpGaD
Lithium—GSK3A—Disease—FGA—osteoporosis	0.000248	0.000471	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL6—osteoporosis	0.000248	0.00047	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—KL—osteoporosis	0.000243	0.000462	CbGpPWpGaD
Lithium—GSK3B—Disease—ACP5—osteoporosis	0.000242	0.000459	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—IL6—osteoporosis	0.000238	0.000452	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—IL6—osteoporosis	0.000237	0.00045	CbGpPWpGaD
Lithium—IMPA1—Metabolism—POMC—osteoporosis	0.000236	0.000448	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—osteoporosis	0.000236	0.000448	CbGpPWpGaD
Lithium—GSK3A—Immune System—PSMA2—osteoporosis	0.000236	0.000448	CbGpPWpGaD
Lithium—GSK3A—Immune System—PSMA5—osteoporosis	0.000236	0.000448	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IRS2—osteoporosis	0.000235	0.000446	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—IL6—osteoporosis	0.000235	0.000446	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TLN1—osteoporosis	0.000232	0.000441	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6R—osteoporosis	0.000226	0.000429	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—IRS2—osteoporosis	0.000225	0.000428	CbGpPWpGaD
Lithium—GSK3B—Disease—TPI1—osteoporosis	0.000225	0.000427	CbGpPWpGaD
Lithium—GSK3A—Disease—ENO1—osteoporosis	0.000221	0.00042	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	0.000221	0.000419	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—osteoporosis	0.000221	0.000419	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—osteoporosis	0.000221	0.000419	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—osteoporosis	0.000219	0.000416	CbGpPWpGaD
Lithium—GSK3B—Immune System—RAP1A—osteoporosis	0.000219	0.000415	CbGpPWpGaD
Lithium—GSK3A—Disease—PSMA2—osteoporosis	0.000218	0.000413	CbGpPWpGaD
Lithium—GSK3A—Disease—PSMA5—osteoporosis	0.000218	0.000413	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MGLL—osteoporosis	0.000218	0.000413	CbGpPWpGaD
Lithium—GSK3B—Immune System—CTSK—osteoporosis	0.000217	0.000412	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—osteoporosis	0.000217	0.000412	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—osteoporosis	0.000216	0.00041	CbGpPWpGaD
Lithium—GSK3B—Immune System—NFATC1—osteoporosis	0.000213	0.000405	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LRP5—osteoporosis	0.000212	0.000403	CbGpPWpGaD
Lithium—GSK3B—Disease—P4HB—osteoporosis	0.000211	0.000401	CbGpPWpGaD
Lithium—GSK3B—Disease—GAPDH—osteoporosis	0.000207	0.000394	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IRS1—osteoporosis	0.000205	0.000389	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LRP6—osteoporosis	0.000203	0.000386	CbGpPWpGaD
Lithium—GSK3A—Disease—CALCA—osteoporosis	0.000203	0.000385	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—LEP—osteoporosis	0.000201	0.000381	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—P4HB—osteoporosis	0.0002	0.00038	CbGpPWpGaD
Lithium—GSK3A—Immune System—KL—osteoporosis	0.0002	0.000379	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AGER—osteoporosis	0.000199	0.000378	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—ADCY5—osteoporosis	0.000198	0.000377	CbGpPWpGaD
Lithium—GSK3B—Disease—NFATC1—osteoporosis	0.000197	0.000374	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—IRS1—osteoporosis	0.000197	0.000374	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—osteoporosis	0.000196	0.000372	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	0.000196	0.000371	CbGpPWpGaD
Lithium—GSK3B—Disease—DKK1—osteoporosis	0.000195	0.000371	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTH—osteoporosis	0.000195	0.00037	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6R—osteoporosis	0.000193	0.000366	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—LEP—osteoporosis	0.000192	0.000365	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RAP1A—osteoporosis	0.000191	0.000364	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CNR2—osteoporosis	0.00019	0.00036	CbGpPWpGaD
Lithium—GSK3B—Disease—WNT1—osteoporosis	0.000188	0.000358	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—osteoporosis	0.000187	0.000356	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NFATC1—osteoporosis	0.000187	0.000355	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DKK1—osteoporosis	0.000185	0.000352	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—osteoporosis	0.000184	0.00035	CbGpPWpGaD
Lithium—GSK3A—Disease—KL—osteoporosis	0.000184	0.00035	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—MYC—osteoporosis	0.000184	0.000349	CbGpPWpGaD
Lithium—GSK3B—Disease—FGA—osteoporosis	0.000183	0.000348	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—WNT1—osteoporosis	0.000178	0.000339	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—MYC—osteoporosis	0.000178	0.000338	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—osteoporosis	0.000176	0.000334	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—osteoporosis	0.000175	0.000333	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—osteoporosis	0.000174	0.000331	CbGpPWpGaD
Lithium—GSK3B—Immune System—PSMA5—osteoporosis	0.000174	0.000331	CbGpPWpGaD
Lithium—GSK3B—Immune System—PSMA2—osteoporosis	0.000174	0.000331	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGA—osteoporosis	0.000174	0.00033	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IRS2—osteoporosis	0.000173	0.00033	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—osteoporosis	0.000173	0.000329	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—POMC—osteoporosis	0.000172	0.000328	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TLN1—osteoporosis	0.000172	0.000326	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—IRS2—osteoporosis	0.000167	0.000316	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGF1—osteoporosis	0.000166	0.000315	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—MYC—osteoporosis	0.000165	0.000314	CbGpPWpGaD
Lithium—GSK3B—Disease—ENO1—osteoporosis	0.000163	0.00031	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—osteoporosis	0.000163	0.00031	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	0.000163	0.00031	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—osteoporosis	0.000163	0.00031	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—osteoporosis	0.000162	0.000307	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTHLH—osteoporosis	0.000161	0.000306	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—BMP2—osteoporosis	0.000161	0.000306	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6R—osteoporosis	0.000161	0.000306	CbGpPWpGaD
Lithium—GSK3B—Disease—PSMA5—osteoporosis	0.000161	0.000306	CbGpPWpGaD
Lithium—GSK3B—Disease—PSMA2—osteoporosis	0.000161	0.000306	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—osteoporosis	0.00016	0.000304	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—osteoporosis	0.00016	0.000303	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGB—osteoporosis	0.000158	0.0003	CbGpPWpGaD
Lithium—GSK3A—Immune System—AGER—osteoporosis	0.000157	0.000298	CbGpPWpGaD
Lithium—GSK3A—Immune System—ADCY5—osteoporosis	0.000156	0.000297	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PSMA2—osteoporosis	0.000152	0.00029	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PSMA5—osteoporosis	0.000152	0.00029	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IRS1—osteoporosis	0.000151	0.000288	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—osteoporosis	0.00015	0.000286	CbGpPWpGaD
Lithium—GSK3B—Disease—CALCA—osteoporosis	0.00015	0.000285	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—P4HB—osteoporosis	0.000148	0.000281	CbGpPWpGaD
Lithium—GSK3B—Immune System—KL—osteoporosis	0.000147	0.00028	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—osteoporosis	0.000147	0.00028	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—IRS1—osteoporosis	0.000145	0.000276	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	0.000144	0.000274	CbGpPWpGaD
Lithium—GSK3A—Disease—ADCY5—osteoporosis	0.000144	0.000274	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTH—osteoporosis	0.000144	0.000273	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6R—osteoporosis	0.000142	0.00027	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CALCA—osteoporosis	0.000142	0.00027	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RAP1A—osteoporosis	0.000141	0.000269	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CNR2—osteoporosis	0.00014	0.000266	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NFATC1—osteoporosis	0.000138	0.000262	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DKK1—osteoporosis	0.000137	0.00026	CbGpPWpGaD
Lithium—GSK3A—Immune System—IRS2—osteoporosis	0.000137	0.00026	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—MYC—osteoporosis	0.000136	0.000259	CbGpPWpGaD
Lithium—GSK3B—Disease—KL—osteoporosis	0.000136	0.000259	CbGpPWpGaD
Lithium—GSK3A—Disease—MTHFR—osteoporosis	0.000133	0.000252	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—WNT1—osteoporosis	0.000132	0.00025	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KL—osteoporosis	0.000129	0.000245	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGA—osteoporosis	0.000128	0.000244	CbGpPWpGaD
Lithium—GSK3A—Disease—IRS2—osteoporosis	0.000126	0.00024	CbGpPWpGaD
Lithium—GSK3A—Immune System—IRS1—osteoporosis	0.000119	0.000227	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—BMP2—osteoporosis	0.000119	0.000226	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTHLH—osteoporosis	0.000119	0.000226	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—osteoporosis	0.000118	0.000225	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGB—osteoporosis	0.000117	0.000222	CbGpPWpGaD
Lithium—GSK3B—Immune System—AGER—osteoporosis	0.000116	0.00022	CbGpPWpGaD
Lithium—GSK3B—Immune System—ADCY5—osteoporosis	0.000115	0.000219	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PSMA5—osteoporosis	0.000113	0.000214	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PSMA2—osteoporosis	0.000113	0.000214	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6R—osteoporosis	0.000112	0.000213	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—osteoporosis	0.000111	0.000211	CbGpPWpGaD
Lithium—GSK3A—Disease—IRS1—osteoporosis	0.00011	0.000209	CbGpPWpGaD
Lithium—GSK3B—Disease—ADCY5—osteoporosis	0.000107	0.000203	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CALCA—osteoporosis	0.000105	0.000199	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6R—osteoporosis	0.000104	0.000197	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADCY5—osteoporosis	0.000101	0.000192	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRS2—osteoporosis	0.000101	0.000192	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—osteoporosis	0.000101	0.000191	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—osteoporosis	9.81e-05	0.000186	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SPP1—osteoporosis	9.78e-05	0.000186	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KL—osteoporosis	9.53e-05	0.000181	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—osteoporosis	9.52e-05	0.000181	CbGpPWpGaD
Lithium—GSK3B—Disease—IRS2—osteoporosis	9.33e-05	0.000177	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—osteoporosis	8.89e-05	0.000169	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IRS2—osteoporosis	8.84e-05	0.000168	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRS1—osteoporosis	8.82e-05	0.000168	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—osteoporosis	8.65e-05	0.000164	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—osteoporosis	8.58e-05	0.000163	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—osteoporosis	8.53e-05	0.000162	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6R—osteoporosis	8.29e-05	0.000157	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ESR1—osteoporosis	8.26e-05	0.000157	CbGpPWpGaD
Lithium—GSK3B—Disease—IRS1—osteoporosis	8.14e-05	0.000155	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IRS1—osteoporosis	7.72e-05	0.000147	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6R—osteoporosis	7.65e-05	0.000145	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADCY5—osteoporosis	7.47e-05	0.000142	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—osteoporosis	7.43e-05	0.000141	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6R—osteoporosis	7.25e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SPP1—osteoporosis	7.22e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—osteoporosis	7.18e-05	0.000136	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—osteoporosis	7.15e-05	0.000136	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IRS2—osteoporosis	6.53e-05	0.000124	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—osteoporosis	6.39e-05	0.000121	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—osteoporosis	6.34e-05	0.00012	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—osteoporosis	6.3e-05	0.00012	CbGpPWpGaD
Lithium—GSK3A—Disease—MYC—osteoporosis	6.14e-05	0.000117	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—osteoporosis	6.12e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ESR1—osteoporosis	6.1e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IRS1—osteoporosis	5.7e-05	0.000108	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—osteoporosis	5.49e-05	0.000104	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6R—osteoporosis	5.36e-05	0.000102	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—osteoporosis	5.28e-05	0.0001	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—osteoporosis	5e-05	9.49e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—osteoporosis	4.61e-05	8.76e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MYC—osteoporosis	4.53e-05	8.61e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—osteoporosis	4.52e-05	8.59e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MYC—osteoporosis	4.3e-05	8.16e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—osteoporosis	4.29e-05	8.14e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—osteoporosis	3.69e-05	7.01e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—osteoporosis	3.41e-05	6.47e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—osteoporosis	3.23e-05	6.13e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MYC—osteoporosis	3.17e-05	6.03e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—osteoporosis	3.17e-05	6.02e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—osteoporosis	2.39e-05	4.53e-05	CbGpPWpGaD
